345 related articles for article (PubMed ID: 20061157)
41. Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors.
Leonetti F; Catto M; Nicolotti O; Pisani L; Cappa A; Stefanachi A; Carotti A
Bioorg Med Chem; 2008 Aug; 16(15):7450-6. PubMed ID: 18585045
[TBL] [Abstract][Full Text] [Related]
42. Structure-activity relationship investigation of benzamide and picolinamide derivatives containing dimethylamine side chain as acetylcholinesterase inhibitors.
Gao XH; Liu LB; Liu HR; Tang JJ; Kang L; Wu H; Cui P; Yan J
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):110-114. PubMed ID: 29166796
[TBL] [Abstract][Full Text] [Related]
43. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
[TBL] [Abstract][Full Text] [Related]
44. Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.
Xie Q; Wang H; Xia Z; Lu M; Zhang W; Wang X; Fu W; Tang Y; Sheng W; Li W; Zhou W; Zhu X; Qiu Z; Chen H
J Med Chem; 2008 Apr; 51(7):2027-36. PubMed ID: 18333606
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
Utku S; Gökçe M; Orhan I; Sahin MF
Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.
Catto M; Pisani L; Leonetti F; Nicolotti O; Pesce P; Stefanachi A; Cellamare S; Carotti A
Bioorg Med Chem; 2013 Jan; 21(1):146-52. PubMed ID: 23199476
[TBL] [Abstract][Full Text] [Related]
47. Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives.
Darvesh S; McDonald RS; Penwell A; Conrad S; Darvesh KV; Mataija D; Gomez G; Caines A; Walsh R; Martin E
Bioorg Med Chem; 2005 Jan; 13(1):211-22. PubMed ID: 15582466
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives.
Wu ZP; Wu XW; Shen T; Li YP; Cheng X; Gu LQ; Huang ZS; An LK
Arch Pharm (Weinheim); 2012 Mar; 345(3):175-84. PubMed ID: 21989769
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
Raza R; Saeed A; Arif M; Mahmood S; Muddassar M; Raza A; Iqbal J
Chem Biol Drug Des; 2012 Oct; 80(4):605-15. PubMed ID: 22726458
[TBL] [Abstract][Full Text] [Related]
50. Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties.
Cappelli A; Gallelli A; Manini M; Anzini M; Mennuni L; Makovec F; Menziani MC; Alcaro S; Ortuso F; Vomero S
J Med Chem; 2005 May; 48(10):3564-75. PubMed ID: 15887964
[TBL] [Abstract][Full Text] [Related]
51. Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors.
Chen X; Tikhonova IG; Decker M
Bioorg Med Chem; 2011 Feb; 19(3):1222-35. PubMed ID: 21232964
[TBL] [Abstract][Full Text] [Related]
52. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
53. Interaction of cycloSal-pronucleotides with cholinesterases from different origins. A structure-activity relationship.
Meier C; Ducho C; Görbig U; Esnouf R; Balzarini J
J Med Chem; 2004 May; 47(11):2839-52. PubMed ID: 15139762
[TBL] [Abstract][Full Text] [Related]
54. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
55. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
Musilek K; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K
Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521
[TBL] [Abstract][Full Text] [Related]
56. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of 4-[(diethylamino)methyl]-phenol derivatives as novel cholinesterase inhibitors with selectivity towards butyrylcholinesterase.
Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Peng W; Song H
Bioorg Med Chem Lett; 2010 Jun; 20(11):3254-8. PubMed ID: 20452769
[TBL] [Abstract][Full Text] [Related]
58. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors.
Pisani L; Catto M; Giangreco I; Leonetti F; Nicolotti O; Stefanachi A; Cellamare S; Carotti A
ChemMedChem; 2010 Sep; 5(9):1616-30. PubMed ID: 20677317
[TBL] [Abstract][Full Text] [Related]
60. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
Loewenstein Y; Gnatt A; Neville LF; Soreq H
J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
